| 18.53 Data as of 12:32pm ET |  -0.08 / -0.43%Today’s Change | 14.41 Today|||52-Week Range 27.25 | -9.57% Year-to-Date |
| Previous close | 18.61 |
| Today’s open | 18.47 |
| Day’s range | 18.33 - 18.67 |
| Volume | 189,339 |
| Average volume (3 months) | 1,223,196 |
| Market cap | $1.3B |
| Dividend yield | -- |
| Earnings growth (last year) | -15.46% |
| Earnings growth (this year) | -88.96% |
| Earnings growth (next 5 years) | +15.13% |
| Revenue growth (last year) | +13.41% |
| P/E ratio | 8.5 |
| Price/Sales | 2.31 |
| Price/Book | 1.84 |
| Today’s change | Today’s % change | |
|---|---|---|
| ACORAcorda Therapeutics ... | +0.11 | +0.34% |
| VVUSVIVUS Inc | +0.78 | +5.77% |
| ACADACADIA Pharmaceutica... | -0.15 | -1.12% |
| SRPTSarepta Therapeutics... | +1.11 | +3.06% |
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | $0.05 |
| Annual revenue (last year) | $581.7M |
| Annual profit (last year) | $55.9M |
| Net profit margin | 9.61% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
President, Chief Executive Officer & Director Chung-Chiang Hsu, PhD |
Chief Financial Officer & Senior Vice President Bryan M. Reasons, MBA, CPA |
Corporate headquarters Hayward, California |
.
